With the analysis among 21,109 patents, we discovered top 453 key players by total patent application. Amgen, Inc., AbbVie, Inc., Regeneron Pharmaceuticals, Inc. are dominant in this area. They take 14.95% of the total patent filing.
California, United States
Patent: 1,527
Illinois, United States
Patent: 850
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 779
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 371
Hounslow, United Kingdom
Patent: 362
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 310
F. Hoffmann-La Roche Ltd.
Illinois, United States
Patent: 291
ZURICH, Switzerland
Patent: 235
With the analysis among 1,117 patents, we discovered top 95 start-ups by total patent application. DRAGONFLY Therapeutics, Inc., Navigo Proteins GmbH, Institut National de la Santé et de la Recherche Médicale are active in this area.
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 371
Niedersachsen, Germany
Patent: 116
Institut National de la Santé et de la Recherche Médicale
Potenza Therapeutics, Inc.
Massachusetts, United States
Patent: 70
Mythic Therapeutics, Inc.
Massachusetts, United States
Patent: 39
Hangzhou Sumgen Biotech Co., Ltd.
Zhejiang Sheng, China
Patent: 20
California, United States
Patent: 18
Bayern, Germany
Patent: 15
Massachusetts, United States
Patent: 14
With the analysis among related 7,330 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Amgen, Inc., DRAGONFLY Therapeutics, Inc., Regeneron Pharmaceuticals, Inc. take 13.57% of patent filing during this period.
California, United States
Patent: 380
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 371
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 244
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 185
Harpoon Therapeutics, Inc.
California, United States
Patent: 103
Regents of the University of California
California, United States
Patent: 95
ZURICH, Switzerland
Patent: 86
Sorrento Therapeutics, Inc.
California, United States
Patent: 73
Dongguan Pengzhi Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 72
With the analysis among related 7,330 patents in last 5 years, we discover 211 new entrants. DRAGONFLY Therapeutics, Inc., Dongguan Pengzhi Biotechnology Co., Ltd., Immatics Biotechnologies GmbH are the most active new entrants in this area.
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 371
Dongguan Pengzhi Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 72
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 59
California, United States
Patent: 41
Harbour BioMed (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 40
Mythic Therapeutics, Inc.
Massachusetts, United States
Patent: 39
California, United States
Patent: 37
Massachusetts, United States
Patent: 24
Washington, United States
Patent: 23
Evotec International GmbH
Hamburg, Germany
Patent: 23
With the analysis among 5,624 patents, we discovered top 256 universities and scientific research institutions by total patent application. President & Fellows of Harvard College, Texas A&M University, The Trustees of Columbia University in The City of New York are dominant in this area. They take 9.67% of the total patent filing.
President & Fellows of Harvard College
Massachusetts, United States
Patent: 133
Texas, United States
Patent: 86
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 80
Washington, United States
Patent: 80
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 71
The Johns Hopkins University
The Rockefeller University
New York, United States
Patent: 62
Osaka-fu, Japan
Patent: 53
University of Saskatchewan
Saskatchewan, Canada
Patent: 51
North Carolina, United States
Patent: 50